Corifollitropin alfa (MK-8962)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Corifollitropin alfa (MK-8962), covering 2021-04-08 to 2021-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043) [Phase 3]